Piper Sandler believes that the overall uptrend in markets remains intact, despite a Wall Street rally triggered by Donald Trump's election win taking a bit of a breather this week. The financial ...
Piper Sandler analyst Biren Amin lowered the firm’s price target on Allogene Therapeutics (ALLO) to $9 from $11 and keeps an Overweight ...
On November 11, Piper Sandler analyst Harsh Kumar released an investor note on the AI market, noting that the CapEx trends at ...
Piper Sandler upgraded Campbell (CPB) to Overweight from Neutral with a price target of $56, up from $47. The firm is citing better long-term ...
Ahead of Nvidia's earnings report, Piper Sandler raised its price target on Nvidia from $140 to $175, maintaining its overweight rating on the stock and calling the stock its top large-cap pick, ...
Piper Sandler upgraded shares of Upstart (NASDAQ:UPST – Free Report) from a neutral rating to an overweight rating in a research report sent to investors on Friday morning, Marketbeat reports.
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC Partners, today announced a strategic alliance.
Warby Parker (NYSE:WRBY – Free Report) had its price objective lifted by Piper Sandler from $18.00 to $22.00 in a research report sent to investors on Friday,Benzinga reports.Piper Sandler ...
Investing.com - Analysts at Piper Sandler have assumed coverage of shares of Block Inc (NYSE:SQ) with an Overweight rating and a $83 price target following the payment company’s Q3 results last ...
Under Trump, bank deal approvals are likely to “speed up markedly and the process will be more clearly delineated,” one ...
Investing.com - Nvidia (NASDAQ:NVDA) is "well-positioned" to capture most of the expected growth in the market for specialized artificial intelligence-enhancing hardware in 2025, analysts at Piper ...
NeoGenomics will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York City.